Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners

Bulletin Express

Mar 04

Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.

The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.

Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1118137844"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118137844\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118137844?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118137844","market":"us","top_or_hot":-1,"title":"Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners","media":"Bulletin Express","content":"<p>Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.</p>\n<p>The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.</p>\n<p>Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaily AESMED (02135) Announces Expected Narrowing of FY2025 Loss and Anticipates RMB2.00 Million Profit Attributable to Owners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-04 19:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.</p>\n<p>The announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.</p>\n<p>Shareholders and investors are advised to exercise caution when dealing in the shares of the Company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02135","symbol_name":"瑞丽医美","start_time":0,"source_url":"","article_id":"1118137844","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118137844","pubTimestamp":1772623306,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02135":"瑞丽医美"},"translate_title":"瑞丽艾斯迈(02135)宣布2025财年亏损预期收窄，预计拥有人应占利润人民币200万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02135":1},"content_text":"Raily Aesthetic Medicine International Holdings Limited projects a loss of approximately RMB2.00 million for the year ended December 31, 2025, notably lower than the RMB63.00 million loss recorded for 2024. The Group also anticipates a profit attributable to the owners of the parent of approximately RMB2.00 million for 2025, compared with a loss of about RMB59.00 million for the prior year.\nThe announcement attributes the improved performance mainly to the absence of the one-off impairment loss recognized in 2024 and an overall improvement in profit margins. The Group’s final consolidated annual results for 2025, expected by the end of March 2026, may be subject to amendments upon completion of the audit review.\nShareholders and investors are advised to exercise caution when dealing in the shares of the Company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}